Published in Nat Med on January 01, 2002
Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol (2007) 3.19
Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity (2006) 2.78
Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol (2012) 2.33
Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol (2008) 1.83
Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol (2006) 1.73
Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett (2008) 1.58
CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol (2010) 1.51
Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol (2009) 1.51
Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol (2009) 1.43
The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J Virol (2008) 1.35
Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection. J Immunol (2008) 1.34
Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J Clin Invest (2012) 1.31
Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol (2011) 1.30
Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol Immunol (2006) 1.30
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev Vaccines (2008) 1.23
Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A (2008) 1.16
Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol (2008) 1.14
Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog (2011) 1.12
Regulation of cytokine production by virus-specific CD8 T cells in the lungs. J Virol (2008) 1.11
Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med (2002) 1.11
Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract. J Virol (2005) 1.09
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A (2008) 1.08
Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol (2013) 1.08
Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J Immunol (2010) 1.06
Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses. J Virol (2003) 1.00
Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res (2009) 1.00
T cell-mediated host immune defenses in the lung. Annu Rev Immunol (2013) 1.00
Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection. J Immunol (2008) 0.99
Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. J Virol (2012) 0.98
Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses. Virol J (2007) 0.97
Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol (2014) 0.96
The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response. J Virol (2006) 0.95
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing (2010) 0.94
Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol (2004) 0.94
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses (2012) 0.93
RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun (2015) 0.92
Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res (2011) 0.91
Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology (2003) 0.90
Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics (2010) 0.88
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein. Virol J (2005) 0.87
Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1. J Leukoc Biol (2010) 0.84
Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol (2014) 0.84
Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection. J Immunol (2012) 0.83
Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice. Vaccine (2012) 0.82
Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges. J Immunol (2014) 0.82
A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. PLoS Pathog (2016) 0.80
RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. J Virol (2008) 0.79
Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats. PLoS One (2016) 0.79
Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A (2014) 0.79
Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice. J Immunol (2013) 0.78
Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype. J Immunol (2015) 0.77
Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity. Clin Exp Immunol (2005) 0.77
Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants. Viruses (2012) 0.77
Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells. Immunology (2015) 0.77
Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe? J Neuroimmunol (2011) 0.76
Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice. J Immunol (2016) 0.76
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Int J Mol Sci (2017) 0.75
Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. Clin Exp Immunol (2015) 0.75
The increased type-1 and type-2 chemokine levels in children with acute RSV infection alter the development of adaptive immune responses. Biomed Res Int (2014) 0.75
Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory Infection. J Immunol (2016) 0.75
Editorial: CD8 T cells cut back on calcium intake in the lungs. J Leukoc Biol (2010) 0.75
Differentiation-dependent differences in murine T cell susceptibility to negative regulation by the lung. Am J Respir Cell Mol Biol (2011) 0.75
Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics. Virology (2017) 0.75
Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain. Sci Rep (2017) 0.75
Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus. J Med Virol (2017) 0.75
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med (2009) 4.22
Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity (2003) 3.49
Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One (2009) 2.70
Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol (2004) 2.50
Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med (2010) 2.22
Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol (2005) 2.13
Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest (2005) 2.07
Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods (2007) 2.04
Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity (2005) 1.99
Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol (2008) 1.85
CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol (2011) 1.75
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med (2010) 1.61
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection. J Infect Dis (2006) 1.46
A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost. Vaccine (2006) 1.43
Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol (2007) 1.23
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. J Virol (2004) 1.15
Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function. J Immunol (2005) 1.13
Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog (2011) 1.12
RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology (2002) 1.06
Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog (2013) 1.05
LFA-1 is required for retention of effector CD8 T cells in mouse lungs. Blood (2003) 1.04
The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS One (2010) 1.03
Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One (2012) 1.01
Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol (2013) 1.01
T cell responses during influenza infection: getting and keeping control. Trends Immunol (2011) 1.00
Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection. J Immunol (2008) 0.99
Role of T cell immunity in recovery from influenza virus infection. Curr Opin Virol (2013) 0.98
Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol (2004) 0.96
Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol (2009) 0.93
Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection. J Virol (2013) 0.92
LAPCs promote follicular helper T cell differentiation of Ag-primed CD4+ T cells during respiratory virus infection. J Exp Med (2012) 0.91
Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells. J Virol (2011) 0.88
Stimulation of naive CD8+ T cells by a variant viral epitope induces activation and enhanced apoptosis. J Immunol (2010) 0.88
Sensitive detection and quantitation of mouse eosinophils in tissues using an enzymatic eosinophil peroxidase assay: its use to rapidly measure pulmonary eosinophilia during experimental respiratory syncytial virus infection of mice. J Immunol Methods (2002) 0.86
Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology (2014) 0.86
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Res (2004) 0.85
The adaptive immune response to respiratory syncytial virus. Curr Top Microbiol Immunol (2013) 0.83
Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract. Curr Opin Virol (2012) 0.82
RSV 2007: recent advances in respiratory syncytial virus research. Viral Immunol (2008) 0.81
The effector T cell response to influenza infection. Curr Top Microbiol Immunol (2015) 0.79
Stress-associated erythropoiesis initiation is regulated by type 1 conventional dendritic cells. J Clin Invest (2015) 0.77
Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation. J Clin Invest (2016) 0.77
Not all effector CD8+ T cells are alike. Microbes Infect (2003) 0.77